Company page

Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a publicly traded company based in the United States, with a market capitalization of approximately $301.65 million. The company focuses on developing innovative cell therapies for various medical conditions. Lineage aims to advance its proprietary technologies to improve patient outcomes and address unmet medical needs.